Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment.

Saved in:
Bibliographic Details
Title: Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment.
Authors: Gisslinger H; Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University Vienna, Vienna, Austria. heinz.gisslinger@meduniwien.ac.at., Klade C; AOP Health, Vienna, Austria., Georgiev P; Medical University of Plovdiv, Plovdiv, Bulgaria., Krochmalczyk D; Teaching Unit of the Hematology Department, University Hospital in Krakow, Krakow, Poland., Gercheva-Kyuchukova L; Clinical Hematology Clinic, Multiprofile Hospital for Active Treatment 'Sveta Marina', Varna, Bulgaria., Egyed M; Department of Internal Medicine II, Kaposi Mor County Teaching Hospital, Kaposvar, Hungary., Dulicek P; Department of Clinical Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic., Illes A; Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Pylypenko H; Department of Hematology, Regional Treatment and Diagnostics Hematology Centre, Cherkasy Regional Oncology Centre, Cherkasy, Ukraine., Sivcheva L; First Department of Internal Medicine, Multiprofile Hospital for Active Treatment - HristoBotev, Vratsa, Bulgaria., Mayer J; Clinic of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Yablokova V; Department of Hematology, Yaroslavl Regional Clinical Hospital, Yaroslavl, Russia., Krejcy K; AOP Health, Vienna, Austria., Empson V; AOP Health, Vienna, Austria., Hasselbalch HC; Department of Hematology, Zealand University Hospital, Roskilde, University of Copenhagen, Copenhagen, Denmark., Kralovics R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Kiladjian JJ; Université de Paris, AP-HP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, CIC1427, Paris, France.
Corporate Authors: PROUD-PV Study Group
Source: Leukemia [Leukemia] 2023 Oct; Vol. 37 (10), pp. 2129-2132. Date of Electronic Publication: 2023 Aug 26.
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5551
DOI:10.1038/s41375-023-02008-6